valganciclovir 450 MG Oral Tablet
Semantic Scholar uses AI to extract papers important to this topic.
Cytomegalovirus (CMV) remains an important pathogen in solid organ transplant patients.
We executed a… (More)
We compared the effectiveness of lower-dose (LD) (450 mg/day for 6 months) to standard-dose (SD) (900 mg/day for 6… (More)
Cytomegalovirus (CMV) prevention can be achieved by prophylaxis or preemptive therapy. We performed a prospective… (More)
- Annals of internal medicine
Cytomegalovirus (CMV) is the most prevalent opportunistic infection after lung transplantation. Current strategies do… (More)
Drug-resistant cytomegalovirus (CMV) infections can cause significant morbidity among high-risk transplant recipients… (More)
The pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir were compared in allogeneic stem… (More)
- The Journal of infectious diseases
We investigated the emergence of cytomegalovirus (CMV) ganciclovir-resistance mutations in 301 high-risk solid-organ transplant… (More)
- Transplantation proceedings
We investigated retrospectively the risk factors for cytomegalovirus (CMV) infection under ganciclovir or valganciclovir… (More)
The clinical patterns and predictors of cytomegalovirus (CMV) disease in kidney and/or pancreas transplant patients on… (More)
▴ Valganciclovir is a prodrug of ganciclovir which has been developed for the treatment of cytomegalovirus (CMV) retinitis in… (More)